Arca
Skip to content
Tools
Tools

Hypogonadism

Drug research and approvals for hypogonadism: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 44 studies of hypogonadism are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 2 approved and 2 open orphan designations naming it.

  • Recruiting worldwide: 44
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 2
  • EU medicines: 0

Recruiting now

Newest posted first, of 44 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Approved 16

Phase 3 9

Phase 2 12

Phase 1 or earlier 3

How its trials ended

345 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 87 whose ending is known, 46% met their primary endpoint, 7% missed it and 47% stopped early.

  • Completed, result not reported18453%
  • Ongoing5215%
  • Met its primary endpoint4012%
  • Stopped: other or unclear257%
  • Status unknown226%
  • Stopped: enrollment or feasibility82%
  • Missed its primary endpoint62%
  • Stopped: lack of efficacy21%
  • Stopped: safety21%
  • Stopped: sponsor or business decision21%
  • Stopped: funding21%

FDA orphan designations

Approved first, then open designations, newest first
Oct 8, 2004LuverisLuveris (lutropin alfa for injection), concomitantly administered with Gonal-f (follitropin alfa for injection), is indicated for…EMD Serono, Inc.Approved
May 24, 2000Gonal-FFor the induction of spermatogenesis in men with primary and secondary hypogonadotropic hypogonadism in whom the cause of infertility is…EMD Serono, Inc.Approved
Dec 5, 1997UrofollitropinFor the initiation and re-initiation of spermatogenesis in adult males with reproductive failure due to hypothalamic or pituitary…EMD Serono, Inc.Designated
Sep 1, 1987SomatropinAdjunct for the induction of ovulation in women with infertility due to hypogonadotropic hypogonadism or bilateral tubal occlusion or…Novo Nordisk PharmaceuticalsDesignated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.